NCT06525948

Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of Transfusion-dependent Non-severe Aplastic Anaemia (TD-NSAA)

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 54 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Investigating the efficacy and safety of rhTPO in combination with cyclosporine versus cyclosporine alone for the treatment of TD-NSAA

Detailed description

Investigating the efficacy and safety of rhTPO in combination with cyclosporine versus cyclosporine alone for the treatment of transfusion-dependent aplastic anaemia of the non-severe type

Conditions

• Aplastic Anemia
• Transfusion-dependent Anemia

Interventions

Type	Name	Description
DRUG	rhTPO	rhTPO
DRUG	Cyclosporin A	cyclosporine A

Timeline

• Start date: 2024-07-30
• Primary completion: 2025-06-30
• Completion: 2025-12-30
• First posted: 2024-07-29
• Last updated: 2024-07-29

Locations

1 site across 1 country: China